FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures

類似資料

• FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas
  著者:: Brown, P J, 等
  出版事項: (2016)
• Vitamin D Receptor Expression in Plasmablastic Lymphoma and Myeloma Cells Confers Susceptibility to Vitamin D
  著者:: Gascoyne, Duncan M., 等
  出版事項: (2016)
• The Forkhead Transcription Factor FOXP2 Is Required for Regulation of p21(WAF1/CIP1) in 143B Osteosarcoma Cell Growth Arrest
  著者:: Gascoyne, Duncan M., 等
  出版事項: (2015)
• N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells
  著者:: Brown, Philip J., 等
  出版事項: (2016)
• CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model
  著者:: Felce, Suet Ling, 等
  出版事項: (2020)